In the context of DN, MMP-9 has been identified as a promising biomarker for type 1 DN (5), while elevated MMP-1 levels in type 2 diabetes have been linked to increased collagenase activity in Schwann cells—a key factor contributing to the development of DN (6). Here, MMP9 is linked to liver dysplastic nodule.